Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
Total Liabilities & Equity
Addex Therapeutics Ltd
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Addex Therapeutics Ltd
SIX:ADXN
|
Total Liabilities & Equity
CHf6.1m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Total Liabilities & Equity
CHf182.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Total Liabilities & Equity
$2.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Total Liabilities & Equity
CHf173.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-5%
|
|
Idorsia Ltd
SIX:IDIA
|
Total Liabilities & Equity
CHf500m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Total Liabilities & Equity
CHf71.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
6.1m
CHF
Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's Total Liabilities & Equity amounts to 6.1m CHF.
What is Addex Therapeutics Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-32%
Over the last year, the Total Liabilities & Equity growth was -50%. The average annual Total Liabilities & Equity growth rates for Addex Therapeutics Ltd have been -33% over the past three years , -32% over the past five years .